Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,107 public trials 2,039 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Improving Communication in Older Cancer Patients and Their Caregivers

NCT02107443

Conditions
Adult Solid Neoplasm, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Delaware/Christiana Care NCORP Newark, Delaware, United States
  • Hawaii Honolulu, Hawaii, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
View all 19 locations
View Trial Details
Completed

A Study of IMC-002 in Subjects With Metastatic or Locally Advanced Solid Tumors and Relapsed or Refractory Lymphomas

NCT04306224

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • Washington University School of Medicine - Siteman Cancer Center St Louis, Missouri, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • NEXT Oncology San Antonio, Texas, United States
  • Seoul National University Hospital Seoul, South Korea
View Trial Details
Completed

Study Evaluating Safety, Tolerability and Clinical Activity of GSK2857916 in Combination With Pembrolizumab in Subjects With Relapsed/Refractory Multiple Myeloma (RRMM)

NCT03848845

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • GSK Investigational Site Atlanta, Georgia, United States
  • GSK Investigational Site Indianapolis, Indiana, United States
  • GSK Investigational Site Charlotte, North Carolina, United States
  • GSK Investigational Site Madison, Wisconsin, United States
View Trial Details
Completed

Blinatumomab in Combination With AMG 404 for the Treatment of Adults With Relapsed or Refractory B Cell Precursor ALL

NCT04524455

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States
View all 19 locations
View Trial Details
Completed

Study of TG-1801 in Subjects With B-Cell Lymphoma

NCT03804996

Conditions
B-cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +12 more
Locations
  • TG Therapeutics Investigational Trial Site Heidelberg, Victoria, Australia
  • TG Therapeutics Investigational Trial Site Melbourne, Victoria, Australia
  • TG Therapeutics Investigational Trial Site Nedlands, Western Australia, Australia
View Trial Details

Related conditions